 | Explain cardiac dysfunction in sepsis, including decreased contractility, impaired ventricular response to fluid therapy, and ventricular dilatation.
|
| Recognize the 60% incidence of global left ventricular hypokinesis in septic shock.
|
| Identify dobutamine as the current "gold standard" in treating myocardial depression in septic shock.
|
| Discuss the proposed future use of Milrinone combined with metoprolol as an alternative to dobutamine in septic shock.
|
| Describe the lack of current research support for recommendation of one specific vasopressor over another in septic shock.
|
| Discuss recent research findings comparing the efficacy of vasopressin plus Levophed versus Levophed alone in septic shock.
|
| Describe the use of high-frequency oscillatory ventilation (HFOV) as a rescue strategy for trauma patients with ARDS.
|
| Explain how maintaining a relatively high constant mean airway with HFOV accomplishes both lung protective ventilation and alveolar recruitment leading to improved oxygenation.
|
| Describe the immunosuppressant effect of PRBC transfusion and discuss the significance of this when considering transfusions in the septic patient.
|
| Discuss the impact of postoperative pulmonary complications on 10 year mortality rates.
|
| Explain the relationship between activation of the abdominal muscles during induction of anesthesia and postoperative pulmonary complications.
|
| Discuss the research evidence concerning polymerized hemoglobin-based oxygen carrier (HBOC) solutions.
|
| Answer commonly asked questions about ventilators, including modes, control variable (pressure or volume), alveolar recruitment measures, and others.
|
| Explain the impact of obesity on negative outcomes in the trauma patient.
|
| Discuss guidelines for care of obese trauma patients. |
